ClinicalTrials.gov
public full text
Public Domain
Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study
The proposed pilot study will estimate the efficacy and safety of a novel therapeutic agent, cabergoline, with a clinical standard therapy, norethindrone acetate, for the treatment of endometriosis-associated pain in young women with endometriosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Relugolix for Endometriosis Associated Pain#1140530
- GnRH Analogues for the Treatment of Endometriosis-Related Pain: A Narrative Review.#409477
- Effectiveness of a Manual Therapy Protocol on Women With Pelvic Pain Due to Endometriosis#905033
- An Overview of Endometriosis and Potential Pharmacogenetic Targets#233290
- Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain#836810
Record · ID 1172815
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive